ISSN: 1523-0864 • Published as 2 vols/year 12 issues each • Online ISSN: 1557-7716
Overview
Antioxidants & Redox Signaling (ARS) is the leading journal dedicated to the understanding of redox principles governing health and disease. This Journal provides and explores key aspects of the important and expanding world of redox-based therapeutics—genetic, pharmacological, and nutritional. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas.
ARS coverage includes:
- ROS/RNS as messengers
- Gaseous signal transducers
- Hypoxia and tissue oxygenation
- microRNA
- Prokaryotic systems
- Lessons from plant biology
ARS is under the editorial leadership of Editor-in-Chief Chandan K. Sen, Wexner Medical Center at The Ohio State University and other leading investigators. View the entire editorial board.
Audience: Cell biologists, molecular biologists, biochemists, medical researchers, and nutritionists, among others.
ARS provides "Instant Online" publication 72 hours after acceptance.
Average time to first decision: 18 days
Average time to triage decision: 48 hours